Purine metabolism in normal and pathologic lymphoid cell differentiation

[1]  S. K. Wadman,et al.  The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. , 1984, Journal of immunology.

[2]  G. Spierenburg,et al.  Purine Interconversion Pathways in T, B, Tγ and T-Tγ Cells from Human Peripheral Blood , 1984 .

[3]  W. Kuis,et al.  Mononuclear cells in S-phase in a patient with purine nucleoside phosphorylase deficiency. , 1984, Advances in experimental medicine and biology.

[4]  C. Figdor,et al.  Lymphocyte Maturation in the Human Thymus , 1983, Scandinavian journal of immunology.

[5]  E. Gelfand,et al.  Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. , 1983, The Journal of biological chemistry.

[6]  A. Hoffbrand,et al.  Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post‐thymic T cells , 1983, British journal of haematology.

[7]  G. Janossy,et al.  The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation. , 1983, Immunology today.

[8]  R. Watts.  Purine enzymes and immune function. , 1983, Clinical Biochemistry.

[9]  G. Spierenburg,et al.  Enzymological studies in chronic lymphocytic leukemia. , 1983, Leukemia research.

[10]  G. Spierenburg,et al.  Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy. , 1983, Leukemia research.

[11]  W. Nyhan,et al.  Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin , 1982 .

[12]  D. Carson,et al.  Characterization of an adenosine 5'-triphosphate- and deoxyadenosine 5'-triphosphate-activated nucleotidase from human malignant lymphocytes. , 1982, Cancer research.

[13]  J. Hadden,et al.  Cyclic nucleotides in mitogen-induced lymphocyte proliferation. , 1982, Immunology today.

[14]  Hoffbrand Av,et al.  Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. , 1982 .

[15]  G. Janossy,et al.  Enzymes of purine metabolism in human peripheral lymphocyte subpopulations. , 1982, Clinical and experimental immunology.

[16]  G. Janossy,et al.  Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. , 1982, Journal of immunology.

[17]  P. Bunn,et al.  Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T‐cell lymphoma , 1982, British journal of haematology.

[18]  R. Kefford,et al.  S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes. , 1982, Cancer research.

[19]  A. Piga,et al.  The effects of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells , 1982, British journal of haematology.

[20]  K. Foon,et al.  Surface markers on leukemia and lymphoma cells: recent advances. , 1982, Blood.

[21]  P. Gearhart.  Generation of immunoglobulin variable gene diversity. , 1982, Immunology today.

[22]  M. Hershfield,et al.  Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Y. Richard,et al.  The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies. , 1982, Leukemia research.

[24]  C. Bruyn,et al.  Purine metabolism in relation to leukemia and lymphoid cell differentiation. , 1982 .

[25]  A. Piga,et al.  THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA , 1981, The Lancet.

[26]  B. Mitchell,et al.  Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. , 1981, Science.

[27]  I. Taylor,et al.  G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine. , 1981, Cancer research.

[28]  A. Piga,et al.  Studies on the Biochemical Sequelae of Therapy in Thy‐Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’Deoxycoformycin , 1981, British journal of haematology.

[29]  M. Tattersall,et al.  Ecto-adenosine triphosphatase deficiency in cultured human T and null leukemic lymphocytes. A biochemical basis for thymidine sensitivity. , 1981, The Journal of clinical investigation.

[30]  J. Kaye,et al.  The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts. , 1981, Journal of immunology.

[31]  J. Habeshaw,et al.  Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. , 1981, Leukemia research.

[32]  H. Dosch,et al.  The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation. , 1980, Journal of immunology.

[33]  B. Mitchell,et al.  Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms. , 1980, Annals of internal medicine.

[34]  L. Parker,et al.  High-dose thymidine infusions in patients with leukemia and lymphoma. , 1980, Blood.

[35]  S. Howell,et al.  Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemia. , 1980, Blood.

[36]  D. Baltimore.  Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes? , 1974, Nature.

[37]  H. Müller-Hermelink,et al.  Characterization of the B-cell and T-cell regions of human lymphatic tissue through enzyme histochemical demonstration of ATPase and 5′-nucleotidase activities , 1974, Virchows Archiv. B, Cell pathology.